Rare therapeutic 'cure' for HIV; Scientists ID brain disease triggers;

Stem Cell Research

In a rare victory against AIDS, German scientists say that three years after a unique stem cell transplant was tried on a patient, "cure of HIV has been achieved in this" man. This is the first time anyone has been pronounced cured of the disease. But as New Scientist notes, their radical therapy strategy offers no hope for the tens of millions of people around the world with the lethal virus. Story

LA-based Capricor has raised $2 million to fuel its work on cardio stem cell therapies. Report

Human umbilical cord blood cells (HUCBs) provide a 'trophic effect' (nutritional effect) that enhances survival and maturation of hippocampal neurons harvested from both young and old laboratory animals, studies examining the activity of human umbilical cord blood cells (HUCB) on experimental models of central nervous system aging, injury and disease, show. Release

Genetics

The human brain contains billions of synapses, links to nerve cells which are composed of proteins. Now a research team has been exploring those proteins and identified a group which play a key role in 130 brain diseases responsible for billions in annual healthcare costs. Story

For the one of the first times in medical history, researchers and physicians at The Medical College of Wisconsin and Children's Hospital of Wisconsin sequenced all the genes in a boy's DNA to identify a previously-unknown mutation. The team was able not only to identify the mutation, but to develop a treatment plan using a cord blood transplant, and stop the course of the disease. Release

Dr. Victor Velculescu of Johns Hopkins University led a team of investigators which determined that brain tumors in children contain significantly fewer genetic mutations, which should help scientists track down new cures. Article

German researchers have identified the FGFR1 as a new suspect in the development of squamous cell lung cancer. News

Cancer Research

The recently identified TRIM24 protein plays an active role in pushing normal breast cells into rapid cell proliferation and, potentially, into breast cancer. Release

Your 'junk' DNA can include a biomarker indicating an increased risk of breast cancer. Story

Suggested Articles

A COVID-19 vaccine developed by a Mass General spinoff is among the candidates emerging from partnerships between tech developers and bio researchers.

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.